ABOUT BAPA

Our Mission

Advocate – Educate – Communicate

We strive to organize Bangladeshi-American Pharmacists in a strong and professional platform so they can be more successful in their career and have a fulfilling experience in this country. We work to get the members involved in the socio-political process that determines their future. We hope to motivate everyone to contribute their time and talent to the betterment of the pharmacy profession here at home and in Bangladesh.

Specifically, the purpose of the organization is to foster cooperation and collaboration among Bangladeshi pharmacists residing in North America; to build and maintain relations with other pharmacists’ associations in North America, to support the profession of pharmacy in Bangladesh and in North America; to support and encourage the development of Pharmaceutical Science in Bangladesh; to develop and conduct programs for maintaining and improving the professional standards; to promote welfare of members’ families in case of need; to protect the professional interests of members of the Association.

Our Sponsors

Silver Sponsor

Bronze Sponsor

Pharmaceutical News

  • Scientists design new drug to fight malaria
    on September 27, 2024 at 8:00 am

    In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance to all antimalarial drugs has posed a big challenge for researchers working to stop the spread of the disease. A team led by scientists at UC Riverside, UC Irvine, and Yale School of Medicine has now designed a new drug against malaria and identified its mechanism of action.

  • Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network
    on September 26, 2024 at 8:00 am

    Bayer announced today the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park at the heart of China's largest biopharma cluster, Zhangjiang, Shanghai. Bayer Co.Lab is part of the global network of life science incubators situated in key innovation hubs, including Cambridge (USA), Kobe (Japan), and Berlin (Germany). The establishment of Bayer Co.Lab Shanghai represents a major milestone in Bayer's external innovation strategy, aimed at fostering open collaboration within the biotechnology ecosystem.

  • Paving the way for new treatments
    on September 25, 2024 at 8:00 am

    A University of Missouri researcher has created a computer program that can unravel the mysteries of how proteins work together - giving scientists valuable insights to better prevent, diagnose and treat cancer and other diseases. Jianlin "Jack" Cheng from Mizzou's College of Engineering and his student, Nabin Giri, have developed a tool called Cryo2Struct that uses artificial intelligence (AI) to build the three-dimensional atomic structure of large protein complexes, work recently published in Nature Communications.

  • Women still missing out on treatment for their No 1 killer - cardiovascular disease
    on September 24, 2024 at 8:00 am

    Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer - cardiovascular disease - despite significant progress in the medical management of heart disease and stroke, concludes a consensus statement published online in the journal Heart. They continue to be underdiagnosed, undertreated, and underrepresented in clinical trials in all areas of cardiovascular disease, says the statement.

  • Nearly 200 potential mammary carcinogens found in food contact materials: new study highlights regulatory shortcomings
    on September 23, 2024 at 8:00 am

    Researchers from the Food Packaging Forum identify and discuss nearly 200 potential breast carcinogens that have been detected in food contact materials (FCMs) on the market. Many nations have food contact material legislation intended to protect citizens from hazardous chemicals, often specifically by regulating genotoxic carcinogens. As cancer is one of the few health endpoints specifically targeted in FCM regulations and testing, carcinogenic chemicals in food packaging and other food contact materials and articles should not be commonplace.